Nifty Pharma Bleeds Red Over Looming Tariffs Comment
Shares of Indian pharmaceutical businesses, including Gland Pharma Ltd, Laurus Labs Ltd, Glenmark Pharmaceuticals Ltd, and Biocon Ltd, dropped as much as 8% on Monday,...
Tag : Gland Pharma Ltd
Gland Pharma Receives Three Observations from USFDA
Gland Pharma Ltd announced on Tuesday, 25 February, that the U.S. Food and Drug Administration (USFDA) has completed a key inspection of its Andhra Pradesh...
Gland Pharma Shares Gain 2% on EIR from USFDA
Shares of Gland Pharma Ltd were trading in the green and 2% higher on 20 January after the company announced receiving Establishment Inspection Report (EIR)...
Gland Pharma Shares Rally 5% on Securing USFDA Approval
Shares of Gland Pharma Ltd rallied 4.99% on 12 December after the company announced securing drug approval from the US Food and Medication Administration (USFDA)....
Gland Pharma Shares Slump 9% as Q1 Earnings Fail to Cheer Investors
Gland Pharma Ltd shares slumped 9% on 7 August after the company announced its quarterly earnings for April-June. The company reported a 25.9% year-on-year decline...
Gland Pharma Shares Slip 2% as USFDA Issued 2 Observations
Shares of Gland Pharma Ltd slipped 2% and hit an intra-day low of Rs 1,978.40 on 25 July after the company announced that the US...
Gland Pharma Shares Slump 3% as 6.2% Stake Changed Hands via Block Deal
Shares of Gland Pharma Ltd were trading in the red and 3% lower on 19 June after 1.02 crore shares of the company changed hands...
Gland Pharma Shares Sank 7% on Block Deal, 5.5% equity worth Rs 1,590 crore changed hands
The shares of Gland Pharma Limited lowered by 7% on April 9, on a block deal that took place where 90.8 lakh shares, or 5.5%...
Gland Pharma Shares Rally 7% on Securing USFDA Approval
Shares of Gland Pharma Ltd were trading in the green and 7% higher on 8 April after the company announced receiving USFDA approval for Eribulin...
Gland Pharma Shares Tumble 2% as Vizag Plant Gets USFDA EIR
The shares of Gland Pharma were trading in the red and 2% lower on 8 November after the company announced that its manufacturing facility in...
